Fisher & Paykel Healthcare Corporation Limited (FSPKF) has released an update.
Fisher & Paykel Healthcare Corporation Limited reported a solid 10% increase in operating revenue to $1.74 billion for FY24, with underlying net profits rising by 6% to $264.4 million, driven by strong demand in hospital consumables and the obstructive sleep apnea mask business. The company has declared a 2% higher annual dividend of 41.5 cents per share, reflecting confidence in their growth trajectory and product innovation, as they prepare for further growth with revenue projections of $1.9 to $2.0 billion for FY25.
For further insights into FSPKF stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
